Culver City, California Saturday, March 1, 2025, 17:00 Hrs [IST] ...

The NK cell therapy market is experiencing significant growth, driven by rising interest in immuno-oncology and advancements in cell engineering technologies. Increasing clinical trials, strategic ...

Discover how hyperbaric oxygen therapy influences telomeres, stem cells, and mitochondria. New research reveals promising ...

The FDA granted RMAT designation to nogapendekin alfa and CAR-NK for reversing lymphopenia in patients with cancer, with ...

CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on innovative CAR T-cell therapies for the treatment of hematologic malignancies and solid tumors, announces that ...

EpimAb_LogoPlanegg/Martinsried and Shanghai, February 27, 2025. Medigene AG (Medigene, FSE: MDG1, Prime Standard) and EpimAb Biotherapeutics, Inc. (EpimAb), announced that the companies have entered ...

Arovella Therapeutics (ASX:ALA) has announced that it has received firm commitments from institutional and sophisticated ...

Feb. 4, 2025 — Research has shown that a potential new targeted therapy for childhood brain cancer is effective in infiltrating and killing tumor cells in preclinical models tested in mice.

The American people have consistently supported life-saving cancer research. Now the nation’s bedrock source of public ...

"Jim brings a specialized skillset and innovative technology experience at the start of what will be a year of momentum for ...

撰文丨王聪编辑丨王多鱼排版丨水成文在肝癌进展过程中，胆汁酸代谢和抗肿瘤免疫均受到扰乱。然而，它们之间复杂的调控关系在很大程度上仍不清楚。2025 年 2 月 25 日，广东省人民医院高平/孙林冲团队与中国科学技术大学张华凤团队合作，在 Cell 子刊 ...

Stem cell research and regenerative medicine are growing markets in the life science sector, and the top stem cell companies ...